AI could help hospitals lower costs, but Fitch said those savings could prompt payers and policymakers to reprice reimbursement.
The analysis appears in Fitch’s “Artificial Intelligence Stress Test” report, published Oct. 5. The report scores 107 subsectors on how adverse AI scenarios could affect their credit over five years. Scores ranged from 0 to 80, and a score of 40 or higher signals potential negative rating action for a typical issuer in the subsector. Healthcare providers scored 20, well below Fitch’s 40-point threshold. Health insurers and medical devices, diagnostics and products companies also scored 20, while pharmaceutical companies scored 30.
The providers score covers Fitch’s corporate-rated providers. Fitch excluded its public finance and sovereign portfolios from the stress test, saying they are “likely to be less affected by the first-order effects in the adverse scenarios.”
Five things to know:
1. Fitch said AI-driven cost reductions in diagnostics, imaging, workflow management and administrative processing could prompt a repricing of reimbursement. It cited “real potential for policy changes affecting profitability in major service lines.”
2. Providers may face higher costs in the near term. Fitch expects them to need heavier investment in digital transformation and AI to stay competitive, which would raise capital and operating expenses and pressure profits and investment budgets.
3. In Fitch’s adverse scenario, repricing combines with competition from lower-cost, AI-enabled entrants that capture low-acuity and routine care volumes. Together, those could lead to some lost patient volumes and service lines, weaker pricing power and margin compression in affected service lines.
4. Even under that scenario, Fitch said the resulting credit pressure would not be material enough to move provider ratings over the next five years. It cited regulatory and licensing barriers, proprietary clinical data, the physical nature of care delivery, and providers’ own use of AI as an operational tailwind.
5. Fitch has not taken any rating actions on healthcare providers in response to AI disruption.
